Oncolytic Viruses
“For difference determined by one gene…”
Rapid Fire
ABSITE Review Thyroid Parathyroid Adrenal January 26, 2012.
page2
EML4-ALK: Oncogene Addiction Meets Personalized Medicine Thomas J Lynch, MD Jonathan and Richard Sackler Professor of Internal Medicine Director, Yale.
J Immunol-2009-Murugaiyan-4169-75_2.pdf
Targeted therapy for Hodgkin’s Lymphoma
Zoledronate does not reduce the risk of treatment failure in osteosarcoma: results of the French multicentre OS2006 randomised trial L Brugières, MC Le.
NY-ESO-1 Specific T Cell Therapy for Patients with Metastatic Sarcoma Seth M. Pollack, MD Associate in Clinical Research, Fred Hutchinson Cancer Research.
Other endpoints in screening studies for Soft Tissue Sarcomas
MEK Inhibitors and their potential role in relapsed NSCLC
